Tamar Rudnick is a healthcare executive who has spent 10+ years in leadership roles across early-stage, public company, and PE-backed businesses. She is currently an Operating Partner at Define Ventures, one of the largest early-stage digital health VCs with ~$800M under management and $22B in exited value.

At Define Ventures, Tamar leads strategic growth initiatives. Based in Silicon Valley, Define invests in early-stage companies from Seed stage to Series B, and has backed and built some of the category-leading companies such as Livongo, HIMS, and Evolent. Define differentiates itself by providing unparalleled expertise in go-to-market and commercialization. Tamar leads this work—developing relationships with a coalition of industry-leading Payers, Health Systems, and Life Sciences companies. To date, Define has delivered customer contracts for over 50% of their portfolio companies.

Prior to Define Ventures, Tamar was the SVP of Growth at apree health, where she was responsible for leading Sales, Enablement, Marketing, and Customer teams across Employer and Health Plan segments. apree health is a leader in tech-enabled primary care delivery for commercial organizations, including Fortune 500 Employers and National Health Plans with Elevance as a key strategic partner. apree health was formed as a combination of Castlight Health and Vera Whole Health. At apree, Tamar led the commercial team, delivering 30% revenue growth for the combined business while integrating two commercial organizations and developing the combined go-to- market strategy.

What you’ll learn about in this episode:

• The current state of the health tech venture capital space
• Trends within the health tech space, including
  • Regulatory trends and shifts that are both positively and negatively impacting the startup space
  • Generative AI’s ability and potential to drive efficiency and reduce operational costs
  • GLP-1s and how they are driving the consumerization of healthcare
• Where AI is having an impact in the healthcare space and how to discern the signal from the noise
• The key findings from Define Ventures' recent study of the health tech space, including a deep dive into funding trends and exits
• The importance of go-to-market and brand strategies in the startup environment

Additional resources: 

• Tamar Rudnick on LinkedIn
• Define Ventures website
• Define Ventures Health Tech Report
• Josh Dougherty on LinkedIn
• Josh Dougherty’s speaking site
• A Brave New’s website